Doctor in Biology from the Autonoma University of Madrid, completed his postdoctoral training at the NCI with scholarships from EMBO and the Fogarty International Center and as Visiting Associate at the LCMB, NCI. He is Research Professor at CSIC He was Secretary General and President of ASEICA, member of the Executive Committees of FESEO and the EACR, member of the Council of FECS and Council of the EACR as a member and Chairman. He is inventor in 16 patent families with 63 applications and the scientific promoter of two spin-off companies focused on cancer diagnosis and treatment. He is actually member of the Advisory Council of MEDES of the Lilly Foundation, member of the Scientific Advisory Board of INCLIVA and Expert of the European Commission. He has published over 200 papers in journals, books, and monographs with an H index of 60 and over 11,000 citations. His major contribution is the discovery of choline kinase as a new biomarker and drug target in oncology and other human diseases.